With so many stakeholders involved in getting a drug from its component chemicals to the pill in the patient's hand, the report from the CGPA and CAPDM stresses the need for harmonized strategy.
The group says these layoffs ‘have significant unintended consequences for reducing American consumers’ access to high-quality, cost-effective healthcare.’